JPMORGAN CHASE & CO - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 62 filers reported holding OVID THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.4%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,195,491
+3864.3%
1,613,409
+3286.2%
0.00%
Q2 2023$156,282
+3025.6%
47,647
+2467.2%
0.00%
Q1 2023$5,000
+124900.0%
1,8560.0%0.00%
Q4 2022$4
-100.0%
1,856
-58.4%
0.00%
Q3 2022$8,000
+14.3%
4,465
+47.0%
0.00%
Q2 2022$7,000
-72.0%
3,038
-62.2%
0.00%
Q1 2022$25,000
+25.0%
8,047
+31.6%
0.00%
Q4 2021$20,000
+25.0%
6,113
+25.2%
0.00%
Q3 2021$16,000
+23.1%
4,882
+50.3%
0.00%
Q2 2021$13,000
-81.9%
3,248
-81.9%
0.00%
Q1 2021$72,000
+46.9%
17,928
-14.9%
0.00%
Q4 2020$49,000
-48.4%
21,064
+32.0%
0.00%
Q3 2020$95,000
-46.9%
15,960
-34.4%
0.00%
Q2 2020$179,000
-29.2%
24,316
-71.3%
0.00%
Q1 2020$253,000
-72.3%
84,853
-61.4%
0.00%
Q4 2019$912,000
+188.6%
219,729
+125.6%
0.00%
Q3 2019$316,000
+145.0%
97,393
+38.7%
0.00%
Q2 2019$129,000
-22.8%
70,226
-25.4%
0.00%
Q1 2019$167,000
-48.6%
94,091
-30.0%
0.00%
Q4 2018$325,000
+4.5%
134,327
+145.0%
0.00%
Q3 2018$311,000
+71.8%
54,832
+136.9%
0.00%
Q2 2018$181,000
-22.3%
23,145
-29.9%
0.00%
Q1 2018$233,000
+316.1%
33,006
+482.8%
0.00%
Q4 2017$56,0005,6630.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
TLS Advisors LLC 1,380,346$3,51618.08%
Madison Avenue Partners, LP 3,104,603$8,009,8761.72%
BVF INC/IL 6,851,051$17,675,7120.65%
CHI Advisors LLC 864,822$2,231,2410.59%
EcoR1 Capital, LLC 6,117,400$15,782,8920.51%
Rubric Capital Management LP 7,001,124$18,062,9000.47%
Artal Group S.A. 2,500,000$6,4500.38%
Tejara Capital Ltd 118,791$306,4810.16%
DCF Advisers, LLC 68,264$176,1200.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 827,580$2,135,1560.06%
View complete list of OVID THERAPEUTICS INC shareholders